collioureviews
Explorer
I've caught wind of arguments on both sides, though only in broad strokes. On one hand, the trials produced outstanding outcomes when 1 injection was given each week; on the other hand, since the half-life sits at roughly 6 days, effectiveness may taper off toward the end of that window, and dividing the dose brings down peak serum concentrations, which softens side effects.
What I'd really like is for someone to pull these threads together. For example, is a weekly 1-shot regimen the better route for a particular person X or objective A, while splitting doses wins out for a different person Y or objective B? Or am I badly mistaken about all this — if so, I'd be glad to be set straight.
What I'd really like is for someone to pull these threads together. For example, is a weekly 1-shot regimen the better route for a particular person X or objective A, while splitting doses wins out for a different person Y or objective B? Or am I badly mistaken about all this — if so, I'd be glad to be set straight.